BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11068859)

  • 1. Cumulative UV radiation dose and outcome in clinical practice: effectiveness of trioxsalen bath PUVA with minimal UVA exposure.
    Snellman E; Rantanen T; Sundell J
    Photodermatol Photoimmunol Photomed; 2000 Oct; 16(5):207-10. PubMed ID: 11068859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized half-side comparison of narrowband UVB and trimethylpsoralen bath plus UVA treatments for psoriasis.
    Snellman E; Klimenko T; Rantanen T
    Acta Derm Venereol; 2004; 84(2):132-7. PubMed ID: 15206693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis.
    Grundmann-Kollmann M; Ludwig R; Zollner TM; Ochsendorf F; Thaci D; Boehncke WH; Krutmann J; Kaufmann R; Podda M
    J Am Acad Dermatol; 2004 May; 50(5):734-9. PubMed ID: 15097957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC; Jeanmougin M
    Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
    Calzavara-Pinton P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA.
    Hannuksela A; Pukkala E; Hannuksela M; Karvonen J
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):685-9. PubMed ID: 8912561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of psoralen - UVA photochemotherapy versus narrow band UVB phototherapy in the treatment of psoriasis.
    Tahir R; Mujtaba G
    J Coll Physicians Surg Pak; 2004 Oct; 14(10):593-5. PubMed ID: 15456547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA.
    Speight EL; Farr PM
    Br J Dermatol; 1994 Nov; 131(5):667-72. PubMed ID: 7999598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phototherapy of psoriasis: comparative experience of different phototherapeutic approaches.
    Karrer S; Eholzer C; Ackermann G; Landthaler M; Szeimies RM
    Dermatology; 2001; 202(2):108-15. PubMed ID: 11306830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
    Turjanmaa K; Salo H; Reunala T
    Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
    Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of skin photosensitivity following trimethylpsoralen bath PUVA.
    Man I; Wainwright NJ; Gibbs NK; Ferguson J
    Photodermatol Photoimmunol Photomed; 2000 Oct; 16(5):211-5. PubMed ID: 11068860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of minimal phototoxic dose and skin type for determining initial UVA dose in oral liquid methoxsalen photochemotherapy for the treatment of psoriasis.
    Rafal ES; Hamilton TA; Gonzalez E
    J Invest Dermatol; 1991 Dec; 97(6):1048-52. PubMed ID: 1748814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
    Koulu LM; Jansén CT
    J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of UV-based therapy for psoriasis.
    Almutawa F; Alnomair N; Wang Y; Hamzavi I; Lim HW
    Am J Clin Dermatol; 2013 Apr; 14(2):87-109. PubMed ID: 23572293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis.
    Kirby B; Buckley DA; Rogers S
    Br J Dermatol; 1999 Apr; 140(4):661-6. PubMed ID: 10233317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
    Cox NH; Farr PM; Diffey BL
    Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J; Gerber W; Hammes S; Ockenfels HM
    Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.